STING was shown to inhibit cervical cancer progression by degrading HPV16/18 E7.[14] We found that the BAG2‐STING axis altered the levels of HPV E7 and its downstream pRb and AKT signaling pathway‐related protein. This evidence concerns the gene RB1 and cervical cancer.